Heron Therapeutics (HRTX) R&D/CAPEX US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 2 340% 2 562% 4 329% 5 891% 3 618%   1 997%  
Changes by years, y/y, % +813pp +222pp +1 767pp +1 562pp -2 273pp     +18.8%

Heron Therapeutics. R&D/CAPEX, %

Heron Therapeutics. R&D/CAPEX, changes, pp

Heron Therapeutics (HRTX) R&D/CAPEX US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
R&D/CAPEX, % 6 321% 1 710% 4 380% 695.8%   1 997%
Changes by years, y/y, % -2 634pp -55 057pp +1 709pp -6 168pp -5 625pp    
Changes by quarters, q/q, % +153pp -4 611pp +2 670pp -4 380pp    

Heron Therapeutics. R&D/CAPEX, %

Heron Therapeutics. R&D/CAPEX, changes, pp

Heron Therapeutics. R&D/CAPEX, changes, pp